The MEDITWIN consortium was officially announced on December 11, 2023, in the presence of the French President and renowned partners such as Dassault Systèmes, seven University Hospital Institutes, Nantes University Hospital, Inria, and associated startups. MEDITWIN aims to introduce personalized virtual twins for organs, metabolism and cancer tumors to improve diagnosis and medical care. This ambitious project will be detailed at the PariSanté Campus event on Thursday December 14, in the presence of Industry Minister Roland Lescure.
The MEDITWIN project will focus on seven new medical practices in the fields of neurology, cardiology and oncology, with the creation of seven “virtual health products“. These advances will be deployed on a sovereign industrial cloud platform. Drawing on the global expertise of its partners, including Dassault Systèmes, Nantes University Hospital, and startups such as inHEART, Codoc, Qairnel, and Neurometers, MEDITWIN is building on the success of virtual twins in other industries to revolutionize healthcare.
The five-year project (2024-2029) will receive financial support from the French government as part of France 2030. MEDITWIN aims to industrialize, clinically validate and standardize the use of virtual twins in the medical field. These advances promise to improve the efficiency of care, the quality of multidisciplinary decisions, and the effectiveness and safety of medical practices and interventions. By establishing standards of care in the form of virtualized experiences, MEDITWIN aspires to become a global benchmark for quality of care and to foster advances in medical science.
Prof. Didier Mutter, CEO, IHU Strasbourg
« Digital twins will be essential elements in the medicine of the future, as they will enable treatments to be simulated in order to provide patients with the most beneficial results possible. MEDITWIN is an extraordinary project in terms of its ambition and the challenges to be met, and it’s also a first for the IHU France alliance to bring together on the same project a multidisciplinary biomedical research power unrivalled anywhere in the world. For the IHU Strasbourg, it will be a powerful powerful boost to improve for improving the minimally invasive management of metastatic colorectal cancer, in close collaboration with two of its historical founders, Inria and the University Hospitals of Strasbourg. »
Read the press release of 11/12/2023 (in French): https://www.3ds.com/fr/newsroom/press-releases/meditwin-launch
